Our top pick for
Building a portfolio
Generation Bio Co is a biotechnology business based in the US. Generation Bio shares (GBIO) are listed on the NASDAQ and all prices are listed in US Dollars. Generation Bio employs 100 staff and has a market cap (total outstanding shares value) of USD0.00.
|52-week range||USD$17.00 - USD$55.72|
|50-day moving average||USD$32.17|
|200-day moving average||USD$31.75|
|Wall St. target price||USD$43.33|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-1.13|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|Gross profit TTM||USD$0|
|Return on assets TTM||-30.15%|
|Return on equity TTM||-56.51%|
|Market capitalisation||USD$1.5 billion|
TTM: trailing 12 months
There are currently 4.2 million Generation Bio shares held short by investors – that's known as Generation Bio's "short interest". This figure is 159.3% up from 1.6 million last month.
There are a few different ways that this level of interest in shorting Generation Bio shares can be evaluated.
Generation Bio's "short interest ratio" (SIR) is the quantity of Generation Bio shares currently shorted divided by the average quantity of Generation Bio shares traded daily (recently around 633626.01503759). Generation Bio's SIR currently stands at 6.65. In other words for every 100,000 Generation Bio shares traded daily on the market, roughly 6650 shares are currently held short.
However Generation Bio's short interest can also be evaluated against the total number of Generation Bio shares, or, against the total number of tradable Generation Bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Generation Bio's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 Generation Bio shares in existence, roughly 70 shares are currently held short) or 0.1183% of the tradable shares (for every 100,000 tradable Generation Bio shares, roughly 118 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Generation Bio.
Find out more about how you can short Generation Bio stock.
We're not expecting Generation Bio to pay a dividend over the next 12 months.
Generation Bio Co. , a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017.
Features, fees and complaints to consider before you apply for a T. Rowe Price account.
Steps to owning and managing ZTO, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZOM, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZKIN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZION, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZNTL, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZGYH, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZEAL, with 24-hour and historical pricing before you buy.
Steps to owning and managing CTIB, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.